Company Filing History:
Years Active: 2013-2014
Title: Rajendra Kharul: Innovator in Diabetes Treatment
Introduction
Rajendra Kharul is a notable inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating type II diabetes. With a total of 2 patents to his name, Kharul's work focuses on innovative solutions to manage blood glucose levels.
Latest Patents
Kharul's latest patents include two key inventions related to glucokinase (GK) activators. The first patent, titled "Substituted benzamide derivatives as glucokinase (GK) activators," describes substituted benzamide derivatives and their pharmaceutically acceptable salts. These compounds are designed to reduce blood glucose levels and increase insulin secretion, providing a potential treatment for type II diabetes. The invention also outlines processes for preparing these compounds and their pharmaceutical compositions.
The second patent, "Disubstituted benzamide derivatives as glucokinase (GK) activators," focuses on disubstituted benzamide derivatives. Similar to the first, this invention includes details on their preparation, pharmaceutical compositions, and methods for treating type II diabetes using these compounds.
Career Highlights
Rajendra Kharul is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing research and development in diabetes treatment.
Collaborations
Kharul has collaborated with notable colleagues, including Mukul R Jain and Pankaj Ramanbhai Patel. Their combined expertise contributes to the innovative research and development efforts at Cadila Healthcare Limited.
Conclusion
Rajendra Kharul's contributions to diabetes treatment through his patented inventions highlight his role as an influential inventor in the pharmaceutical field. His work continues to pave the way for advancements in managing type II diabetes effectively.